Annual Total Debt
$2.70 B
+$1.50 M+0.06%
31 December 2023
Summary:
Regeneron Pharmaceuticals annual total debt is currently $2.70 billion, with the most recent change of +$1.50 million (+0.06%) on 31 December 2023. During the last 3 years, it has risen by +$7.20 million (+0.27%). REGN annual total debt is now at all-time high.REGN Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$2.70 B
+$400.00 K+0.01%
30 September 2024
Summary:
Regeneron Pharmaceuticals quarterly total debt is currently $2.70 billion, with the most recent change of +$400.00 thousand (+0.01%) on 30 September 2024. Over the past year, it has increased by +$1.40 million (+0.05%). REGN quarterly total debt is now at all-time high.REGN Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Total Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +0.1% | +0.1% |
3 y3 years | +0.3% | +0.2% |
5 y5 years | +281.5% | +279.4% |
REGN Total Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +0.3% | at high | +0.2% |
5 y | 5 years | at high | +281.5% | at high | +279.4% |
alltime | all time | at high | at high |
Regeneron Pharmaceuticals Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $2.70 B(+0.0%) |
June 2024 | - | $2.70 B(+0.0%) |
Mar 2024 | - | $2.70 B(+0.0%) |
Dec 2023 | $2.70 B(+0.1%) | $2.70 B(+0.0%) |
Sept 2023 | - | $2.70 B(+0.0%) |
June 2023 | - | $2.70 B(+0.0%) |
Mar 2023 | - | $2.70 B(+0.0%) |
Dec 2022 | $2.70 B(+0.1%) | $2.70 B(+0.0%) |
Sept 2022 | - | $2.70 B(+0.0%) |
June 2022 | - | $2.70 B(+0.0%) |
Mar 2022 | - | $2.70 B(+0.0%) |
Dec 2021 | $2.70 B(+0.1%) | $2.70 B(+0.0%) |
Sept 2021 | - | $2.70 B(+0.0%) |
June 2021 | - | $2.70 B(+0.0%) |
Mar 2021 | - | $2.70 B(+0.0%) |
Dec 2020 | $2.70 B(+277.6%) | $2.70 B(+0.0%) |
Sept 2020 | - | $2.69 B(+21.6%) |
June 2020 | - | $2.22 B(+209.8%) |
Mar 2020 | - | $715.20 M(+0.2%) |
Dec 2019 | $713.90 M(+0.8%) | $713.90 M(+0.2%) |
Sept 2019 | - | $712.70 M(+0.2%) |
June 2019 | - | $711.30 M(+0.2%) |
Mar 2019 | - | $709.90 M(+0.2%) |
Dec 2018 | $708.50 M(+0.7%) | $708.50 M(+0.2%) |
Sept 2018 | - | $707.20 M(+0.2%) |
June 2018 | - | $705.90 M(+0.2%) |
Mar 2018 | - | $704.64 M(+0.2%) |
Dec 2017 | $703.50 M(+46.2%) | $703.50 M(+0.2%) |
Sept 2017 | - | $702.32 M(+0.2%) |
June 2017 | - | $701.17 M(-0.9%) |
Mar 2017 | - | $707.61 M(+47.1%) |
Dec 2016 | $481.13 M(+32.6%) | $481.13 M(+25.9%) |
Sept 2016 | - | $382.23 M(+5.7%) |
June 2016 | - | $361.52 M(-0.2%) |
Mar 2016 | - | $362.23 M(-0.2%) |
Dec 2015 | $362.92 M(-20.7%) | $362.92 M(-8.1%) |
Sept 2015 | - | $394.87 M(+1.8%) |
June 2015 | - | $388.05 M(-17.9%) |
Mar 2015 | - | $472.48 M(+3.2%) |
Dec 2014 | $457.71 M(-9.3%) | $457.71 M(-19.0%) |
Sept 2014 | - | $565.31 M(+9.2%) |
June 2014 | - | $517.85 M(-2.5%) |
Mar 2014 | - | $531.11 M(+5.3%) |
Dec 2013 | $504.57 M(+10.3%) | $504.57 M(+4.6%) |
Sept 2013 | - | $482.18 M(+1.9%) |
June 2013 | - | $473.30 M(+2.3%) |
Mar 2013 | - | $462.75 M(+1.2%) |
Dec 2012 | $457.33 M(+5.0%) | $457.33 M(+1.2%) |
Sept 2012 | - | $451.74 M(+1.2%) |
June 2012 | - | $446.23 M(+1.2%) |
Mar 2012 | - | $440.83 M(+1.2%) |
Dec 2011 | $435.53 M(+172.2%) | $435.53 M(+171.5%) |
Sept 2011 | - | $160.40 M(+0.0%) |
June 2011 | - | $160.33 M(+0.1%) |
Mar 2011 | - | $160.15 M(+0.1%) |
Dec 2010 | $160.03 M(+46.8%) | $160.03 M(+0.6%) |
Sept 2010 | - | $159.02 M(+0.8%) |
June 2010 | - | $157.81 M(+0.6%) |
Mar 2010 | - | $156.90 M(+43.9%) |
Dec 2009 | $109.02 M(>+9900.0%) | $109.02 M(+74.2%) |
Sept 2009 | - | $62.57 M(-0.6%) |
June 2009 | - | $62.92 M(>+9900.0%) |
Mar 2009 | - | $0.00(0.0%) |
Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
Sept 2008 | - | $117.50 M(-1.0%) |
June 2008 | - | $118.65 M(-40.7%) |
Mar 2008 | - | $200.00 M(0.0%) |
Dec 2007 | $200.00 M | $200.00 M(0.0%) |
Sept 2007 | - | $200.00 M(0.0%) |
Date | Annual | Quarterly |
---|---|---|
June 2007 | - | $200.00 M(0.0%) |
Mar 2007 | - | $200.00 M(0.0%) |
Dec 2006 | $200.00 M(0.0%) | $200.00 M(0.0%) |
Sept 2006 | - | $200.00 M(0.0%) |
June 2006 | - | $200.00 M(0.0%) |
Mar 2006 | - | $200.00 M(0.0%) |
Dec 2005 | $200.00 M(0.0%) | $200.00 M(0.0%) |
Sept 2005 | - | $200.00 M(0.0%) |
June 2005 | - | $200.00 M(0.0%) |
Mar 2005 | - | $200.00 M(0.0%) |
Dec 2004 | $200.00 M(-6.5%) | $200.00 M(0.0%) |
Sept 2004 | - | $200.00 M(0.0%) |
June 2004 | - | $200.00 M(0.0%) |
Mar 2004 | - | $200.00 M(-6.5%) |
Dec 2003 | $213.82 M(+6.8%) | $213.82 M(+2.2%) |
Sept 2003 | - | $209.30 M(+2.0%) |
June 2003 | - | $205.15 M(+2.5%) |
Mar 2003 | - | $200.06 M(-0.0%) |
Dec 2002 | $200.15 M(-0.2%) | $200.15 M(-0.0%) |
Sept 2002 | - | $200.24 M(-0.0%) |
June 2002 | - | $200.32 M(-0.1%) |
Mar 2002 | - | $200.47 M(-0.1%) |
Dec 2001 | $200.58 M(+7381.4%) | $200.58 M(+9147.4%) |
Sept 2001 | - | $2.17 M(-6.4%) |
June 2001 | - | $2.32 M(-5.5%) |
Mar 2001 | - | $2.45 M(-8.6%) |
Dec 2000 | $2.68 M(-34.6%) | $2.68 M(-10.7%) |
Sept 2000 | - | $3.00 M(-12.8%) |
June 2000 | - | $3.44 M(-11.1%) |
Mar 2000 | - | $3.87 M(-5.6%) |
Dec 1999 | $4.10 M(-2.4%) | $4.10 M(+24.2%) |
Sept 1999 | - | $3.30 M(-10.8%) |
June 1999 | - | $3.70 M(-5.1%) |
Mar 1999 | - | $3.90 M(-7.1%) |
Dec 1998 | $4.20 M(-25.0%) | $4.20 M(-6.7%) |
Sept 1998 | - | $4.50 M(-6.3%) |
June 1998 | - | $4.80 M(0.0%) |
Mar 1998 | - | $4.80 M(-14.3%) |
Dec 1997 | $5.60 M(-35.6%) | $5.60 M(-17.6%) |
Sept 1997 | - | $6.80 M(-6.8%) |
June 1997 | - | $7.30 M(-6.4%) |
Mar 1997 | - | $7.80 M(-10.3%) |
Dec 1996 | $8.70 M(-8.4%) | $8.70 M(-3.3%) |
Sept 1996 | - | $9.00 M(+4.7%) |
June 1996 | - | $8.60 M(-1.1%) |
Mar 1996 | - | $8.70 M(-8.4%) |
Dec 1995 | $9.50 M(-22.8%) | $9.50 M(-7.8%) |
Sept 1995 | - | $10.30 M(-6.4%) |
June 1995 | - | $11.00 M(+26.4%) |
Mar 1995 | - | $8.70 M(-29.3%) |
Dec 1994 | $12.30 M(+64.0%) | $12.30 M(+19.4%) |
Sept 1994 | - | $10.30 M(+9.6%) |
June 1994 | - | $9.40 M(-21.0%) |
Mar 1994 | - | $11.90 M(+58.7%) |
Dec 1993 | $7.50 M(+10.3%) | $7.50 M(-2.6%) |
Sept 1993 | - | $7.70 M(-1.3%) |
June 1993 | - | $7.80 M(+1.3%) |
Mar 1993 | - | $7.70 M(+13.2%) |
Dec 1992 | $6.80 M(+142.9%) | $6.80 M(+9.7%) |
Sept 1992 | - | $6.20 M(+8.8%) |
June 1992 | - | $5.70 M(+18.8%) |
Mar 1992 | - | $4.80 M(+71.4%) |
Dec 1991 | $2.80 M(>+9900.0%) | $2.80 M(+250.0%) |
Sept 1991 | - | $800.00 K(+100.0%) |
June 1991 | - | $400.00 K(>+9900.0%) |
Mar 1991 | - | $0.00(0.0%) |
Dec 1990 | $0.00 | $0.00(0.0%) |
Sept 1990 | - | $0.00(0.0%) |
June 1990 | - | $0.00(0.0%) |
Mar 1990 | - | $0.00 |
FAQ
- What is Regeneron Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual total debt year-on-year change?
- What is Regeneron Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly total debt year-on-year change?
What is Regeneron Pharmaceuticals annual total debt?
The current annual total debt of REGN is $2.70 B
What is the all time high annual total debt for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual total debt is $2.70 B
What is Regeneron Pharmaceuticals annual total debt year-on-year change?
Over the past year, REGN annual total debt has changed by +$1.50 M (+0.06%)
What is Regeneron Pharmaceuticals quarterly total debt?
The current quarterly total debt of REGN is $2.70 B
What is the all time high quarterly total debt for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly total debt is $2.70 B
What is Regeneron Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, REGN quarterly total debt has changed by +$1.40 M (+0.05%)